Unknown

Dataset Information

Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.


ABSTRACT:

Objectives

Noroviruses (NoVs) are major cause of acute viral gastroenteritis in worldwide, and the lack of a cell culture system that must be considered the virus like particles (VLPs) are used as an effective vaccine development.

Materials and methods

In the present study, we investigated the expression of the major capsid protein (VP1) of the Genogroup II, genotype 17 (GII.17) NoV, using recombinant baculovirus system in insect cells, as well as a saliva binding blockade assay to detect their protective potency.

Results

Our results showed that GII.17 VLPs could be successfully generated in sf9 insect cells, and electron microscopic revealed that GII.17 VLPs appeared as spherical particles with a - 35 nm diameter. Immunized mice with purified VLPs produced GII.17 spe

SUBMITTER: Chen W 

PROVIDER: S-EPMC7223773 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature